21 May 2009
Early postoperative complications of expanded criteria living kidney donors’ nephrectomies
R Kieszek, M Bieniasz, P Domagała, J Gozdowska, A Kwiatkowski, L Adadyński, J Trzebicki, M Durlik, L Pączek, A ChmuraAnn Transplant 2009; 14(1): 58-58 :: ID: 880411
Abstract
Background: Organs from living donors with expanded criteria (ECLD) are one of the ways to increase the number of transplantations. There is no comprehensive definition of this status. The aim of this study was to analyse early postoperative complications of living kidney donors' with expanded criteria versus optimal donors' postoperative complications.
Material/Methods: The records of 76 living donors were reviewed. Those
included age, BMI, hypertension, lipid disorders as the major risk factors (2
points each), gout, nephrolithiasis, nephrocysts, renal disorders in the family
diabetes, smoking history, HBC and HCV infections, venous thromboembolism, mental health disorders and vascular abnormalities as minor risk factors (1 point each). Patients were divided into two groups, optimal patients (0-5 points) and expanded criteria patients (6 points and more). There were 69 patients in the first group, 7 patients in the second group.
Results: There were three patients with diagnosed complications in the expanded criteria group (42.8%), and twenty two patients with diagnosed complication in the optimal group (OLD) (31.9%).
Conclusions: Nephrectomy in living kidney donors with expanded criteria is safe and there is no higher risk of early postoperative complications.
Keywords: Kidney Transplantation, Living Donors
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






